Kanagawa-ken, Japan

Masanori Seki




Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masanori Seki: Innovator in Pharmaceutical Development

Introduction

Masanori Seki is a notable inventor based in Kanagawa-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents, his work is focused on innovative solutions for health-related challenges.

Latest Patents

One of Masanori Seki's latest patents involves pyrimidine derivatives that are useful for the treatment of diseases mediated by CRTH2. This invention relates to a pyrimidine derivative of a specific formula and its salts, which serve as active ingredients in pharmaceutical preparations. The pyrimidine derivative exhibits excellent antagonistic activity against CRTH2, a G-protein-coupled chemoattractant receptor expressed on Th2 cells. This compound can be utilized for the prophylaxis and treatment of various diseases associated with CRTH2 activity, including allergic diseases such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis. Additionally, it addresses eosinophil-related diseases like Churg-Strauss syndrome and sinusitis, as well as basophil-related diseases such as basophilic leukemia and chronic urticaria. Furthermore, it has applications in treating inflammatory diseases characterized by T lymphocytes and significant leukocyte infiltrates, including psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, chronic obstructive pulmonary disorder (COPD), and arthritis.

Career Highlights

Masanori Seki is currently associated with Actimis Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is instrumental in advancing treatments that improve patient outcomes and address unmet medical needs.

Collaborations

Masanori collaborates with talented individuals in his field, including Tai-wei Ly and Yuji Koriyama. These partnerships enhance the research and development efforts at Actimis Pharmaceuticals, Inc.

Conclusion

Masanori Seki's contributions to pharmaceutical innovations, particularly through his patents on pyrimidine derivatives, highlight his commitment to improving healthcare solutions. His work exemplifies the impact of dedicated inventors in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…